Red Arrow Therapeutics
Latest round
- Seed
Last raised
- Apr 2024
Total raised
- $4.4M
Investors
- 4
About Red Arrow Therapeutics
Based in Tokyo, Japan, and founded in 2021 by Chief Executive Officer Takuya Miyazaki, co-founders Horacio Cabral and Rika Tajima, Red Arrow Therapeutics, Inc. operates as a nanotechnology company developing an innovative drug delivery system with nanotechnology. In April 2024, Red Arrow Therapeutics, Inc. Red Arrow Therapeutics, Inc. develops nanotechnology-based treatments for supporting patients with cancer treatment. The company’s technology includes small peptides to antibody full chains and cationic proteins to anionic proteins. It offers nanopolymer cytokine micelles, which get injected and affect pores in cancer microvessels to the tumor microenvironment. In addition, the firm’s pipeline includes RA-001 and RA-002 for converting cold tumors to hot, RA-003 for collaborating with pharma, and RA-004 (nucleic acids).
Who invested in Red Arrow Therapeutics
4 investors across 1 round
See all investors in Red Arrow Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Apr 23, 2024
Amount
$4.4M
Investors
Questions about Red Arrow Therapeutics
Who invested in Red Arrow Therapeutics?
Red Arrow Therapeutics has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Red Arrow Therapeutics raised?
Red Arrow Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Red Arrow Therapeutics last raise money?
Red Arrow Therapeutics's most recent round on record is a Seed, in Apr 2024.
What does Red Arrow Therapeutics do?
Based in Tokyo, Japan, and founded in 2021 by Chief Executive Officer Takuya Miyazaki, co-founders Horacio Cabral and Rika Tajima, Red Arrow Therapeutics, Inc.
Where is Red Arrow Therapeutics headquartered?
Red Arrow Therapeutics is headquartered in Tokyo, Japan.
Which VCs invest in companies like Red Arrow Therapeutics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Red Arrow Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Red Arrow Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.